Table 2 shows details of pancreatitis cases associated with GLP-1 RA drugs, including 12 fatalities, four disabilities, 208 hospitalizations, and 12 life-threatening cases, as well as one case requiring immediate intervention to prevent irreversible harm
Johansen NJ, Dejgaard TF, Lund A et al (2020) Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
Ice crystal formation can physically damage the peptide structure
Check with HR or the plan document
Non ABCD members Non ABCD members are welcome to take part in the audit and will be given access to the on-line audit tool when they register for the audit